These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 7775115
21. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ. Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882 [Abstract] [Full Text] [Related]
23. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ. Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281 [Abstract] [Full Text] [Related]
24. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Zaidi TS, Priebe GP, Pier GB. Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743 [Abstract] [Full Text] [Related]
25. In vivo activity of proteases of Pseudomonas aeruginosa in a rat model. Döring G, Dalhoff A, Vogel O, Brunner H, Dröge U, Botzenhart K. J Infect Dis; 1984 Apr; 149(4):532-7. PubMed ID: 6427361 [Abstract] [Full Text] [Related]
26. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases. Kreger AS, Lyerly DM, Hazlett LD, Berk RS. Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522 [Abstract] [Full Text] [Related]
27. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. Döring G, Obernesser HJ, Botzenhart K, Flehmig B, Høiby N, Hofmann A. J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993 [Abstract] [Full Text] [Related]
28. Degradation of uniquely glycosylated secretory immunoglobulin a in tears from patients with Pseudomonas aeruginosa keratitis. Lomholt JA, Kilian M. Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4939-44. PubMed ID: 18757515 [Abstract] [Full Text] [Related]
32. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Kernacki KA, Berk RS. Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):16-23. PubMed ID: 7822143 [Abstract] [Full Text] [Related]
33. Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa. Berk RS, Dong Z, Alousi S, Kosir MA, Wang Y, Vlodavsky I. Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1182-7. PubMed ID: 15037586 [Abstract] [Full Text] [Related]
36. Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa. Berk RS, Katar M, Dong Z, Day DE. Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1561-7. PubMed ID: 11381061 [Abstract] [Full Text] [Related]
37. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM. Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953 [Abstract] [Full Text] [Related]
38. An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model. Cowell BA, Willcox MD, Hobden JA, Schneider RP, Tout S, Hazlett LD. Exp Eye Res; 1998 Sep; 67(3):347-56. PubMed ID: 9778416 [Abstract] [Full Text] [Related]